OTTAWA – The Honourable Leona Aglukkaq, Minister of Health, today announced that Canada’s Food and Drug Regulations will become even stronger.
Currently in Canada, internationally accepted high quality standards – known as Good Manufacturing Practices (GMP) – are required for the production of pharmaceutical drugs. To make sure that the health and safety of Canadian consumers and their families are even more protected, the active ingredients (AI) in these drugs will be subject to these same standards. An AI is the ingredient or combination of ingredients in a drug that delivers a health benefit to a patient. An example of a common AI is acetaminophen, which is used in the pain-reliever Tylenol.
These stronger regulations will improve the safety of drugs used by Canadians and their families